Highlights in Breast Cancer from 2021- Updates from ESMO and SABCS


  • Discuss the most current research and advances in the field of breast cancer with colleagues
  • Review and critically assess practice-changing results of emerging breast cancer research
  • Propose best practices for implementing therapeutic strategies in the management of patients with breast cancer.



Monday, December 13, 2021

Local Time

  • Timezone: America/New_York
  • Date: Monday, December 13, 2021
  • Time: 7:00 pm - 8:00 pm


Registration is complimentary for healthcare professionals and can be completed below.

Book Event


1 Ticket selected.

Available Tickets: Unlimited

The Webinar ticket is sold out. You can try another ticket or another date.

personAbout the Faculty

Dr. Jan-Willem Henning

Jan-Willem Henning, MBChB, FRCPC


Dr. Jan-Willem Henning works at the Tom Baker Cancer Centre, as a staff Medical Oncologist and Clinical Assistant Professor. His areas of clinical interests include breast cancer and sarcoma malignancies. Dr. Henning’s research interests include conducting health services and patient outcomes research. In addition, Dr. Henning is a lead and co-investigator of Cooperative Group Trials, as well as Pharmaceutical Sponsored Clinical Trials and his researched has been published in peer and non[1]peer medical journals. His academic interests involve the education of Internal Medicine and Medical Oncology residents at the University of Calgary, Post-Graduate Medical Educational Program. He is the immediate past Program Director for the Medical Oncology Residency Program at Tom Baker Cancer Centre (2016-2020) and currently fulfills the Vice-Chair position of the Royal College Medical Oncology Subspecialty Committee.

Nadia Califaretti_Photo 2020.12

Nadia Califaretti, MD FRCPC


Nadia Califaretti is a graduate of the University of Toronto Medical School. She completed her specialty training in Oncology at the University of Toronto, Princess Margaret Hospital. She completed her Fellowship in Breast Cancer and Autologous Blood/Bone Marrow Transplantation at the PMH/UHN in 2000.

She has been a staff medical oncologist at Grand River Regional Cancer Centre since 2001. Nadia treats breast, lung and gynecological malignancies.

Her special clinical interest has always been neoadjuvant therapy for early/locally advanced breast cancer, and she has been a Principal Investigator for numerous CCTG and industry-sponsored phase II/III trials in the adjuvant/metastatic/supportive care setting. She has served as Chair of her local Breast Disease Site Group and Breast Multidisciplinary Case Conference Group. She currently serves as Physician Lead of the GRRCC Clinical Trials Department. She collaborates on metabolism and breast cancer research with the University of Waterloo. She enjoys teaching/mentoring in her capacity as Assistant Clinical Professor (Adjunct) of Oncology, McMaster University. She participates in Guideline review for the CCO Program in Evidence-Based Care, and she has served as a manuscript reviewer for The Oncologist and Journal of Clinical Medicine.

Aalok Kumar 2020

Aalok Kumar, MD, MHSc, FRCPC


Dr. Aalok Kumarcompleted medical school at the University of Toronto, and went on to do his Internal Medicine training at McMaster University. He then moved out west and completed his medical oncology training along with a fellowship in medical gyne-oncology at BC Cancer/UBC. He has also completed his Masters of Health Sciences at UBC. He currently works as a medical oncologist at BC Cancer Surrey treating patients with breast and gynecological malignancies and is also actively involved in clinical trials and health outcomes research.  ​